AAAAAA

   
Results: 1-22 |
Results: 22
PRIMARY CHYLOUS ASCITIS IN PATIENTS WITH LIVER-CIRRHOSIS - DESCRIPTION OF 2 NEW CASES
Authors: CANCELA MA SOUTO F NUNEZ MJ CARO MC PINEIRO L
Citation: Ma. Cancela et al., PRIMARY CHYLOUS ASCITIS IN PATIENTS WITH LIVER-CIRRHOSIS - DESCRIPTION OF 2 NEW CASES, Revista espanola de enfermedades digestivas, 90(8), 1998, pp. 596-597
A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL)
Authors: SCHILLER G STEWART AK BALLESTER O NOGA S RUGO H FREYTES C STADTMAUER E KOGUT N TARANFOLO S STIFF P PINEIRO L DALTON W HO A VESCIO R BENYUNES M JACOBS C DIPERSIO J ANDERSON K BERENSON J
Citation: G. Schiller et al., A PHASE-III STUDY EVALUATING CD34(-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED MULTIPLE-MYELOMA - ENGRAFTMENT RESULTS() SELECTED VERSUS UNSELECTED AUTOLOGOUS PERIPHERAL), Blood, 90(10), 1997, pp. 960-960
EFFICACY OF ORAL GANCICLOVIR (GAN) FOR PREVENTION OF CMV INFECTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: PINEIRO L SKETTINO S TAN J STEMPIEN MJ
Citation: L. Pineiro et al., EFFICACY OF ORAL GANCICLOVIR (GAN) FOR PREVENTION OF CMV INFECTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 2425-2425
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP
Authors: BROWN RA WOLFF SN FAY JW PINEIRO L COLLINS RH LYNCH JP STEVENS D GREER J HERZIG RH HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP, Leukemia & lymphoma, 22(3-4), 1996, pp. 271-277
ALLOGENEIC BLOOD-CELL TRANSPLANTATION WITHOUT POSTTRANSPLANT COLONY-STIMULATING FACTORS IN PATIENTS WITH HEMATOPOIETIC NEOPLASM - A PHASE-II STUDY
Authors: ROSENFELD C COLLINS R PINEIRO L AGURA E NEMUNAITIS J
Citation: C. Rosenfeld et al., ALLOGENEIC BLOOD-CELL TRANSPLANTATION WITHOUT POSTTRANSPLANT COLONY-STIMULATING FACTORS IN PATIENTS WITH HEMATOPOIETIC NEOPLASM - A PHASE-II STUDY, Journal of clinical oncology, 14(4), 1996, pp. 1314-1319
HIV-ASSOCIATED RESPIRATORY-DISEASE
Authors: NUNEZ MJ PINEIRO L
Citation: Mj. Nunez et L. Pineiro, HIV-ASSOCIATED RESPIRATORY-DISEASE, Lancet, 348(9031), 1996, pp. 893-893
PREVENTION OF GRAFT-VERSUS-HOST (GVHD) AFTER UNRELATED MARROW TRANSPLANTATION THERAPY (UMT) USING TACROLIMUS (FK506) AND PREDNISONE
Authors: FAY JW AGURA E COLLINS R PINEIRO L
Citation: Jw. Fay et al., PREVENTION OF GRAFT-VERSUS-HOST (GVHD) AFTER UNRELATED MARROW TRANSPLANTATION THERAPY (UMT) USING TACROLIMUS (FK506) AND PREDNISONE, Blood, 88(10), 1996, pp. 1660-1660
DOES CD38 CONTENT OF ALLOGENEIC BLOOD-CELL - TRANSPLANTS PREDICT ACUTE GVHD
Authors: ROSENFELD CS WEINTHAL JW COLLINS RW AGURA ED LENARSKY C PINEIRO L NEMUNAITIS J FAY JW
Citation: Cs. Rosenfeld et al., DOES CD38 CONTENT OF ALLOGENEIC BLOOD-CELL - TRANSPLANTS PREDICT ACUTE GVHD, Blood, 88(10), 1996, pp. 2453-2453
ALLOGENEIC TRANSPLANTATION COMBINING MOBILIZED BLOOD AND BONE-MARROW IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES
Authors: NEMUNAITIS J ROSENFELD C COLLINS R PALLANSCH P PINEIRO L OHR S WAXMAN D STONE M FAY J MILLER W SHADDUCK R
Citation: J. Nemunaitis et al., ALLOGENEIC TRANSPLANTATION COMBINING MOBILIZED BLOOD AND BONE-MARROW IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES, Transfusion, 35(8), 1995, pp. 666-673
ALLOGENEIC BLOOD-CELL TRANSPLANTATION WITHOUT POSTTRANSPLANT COLONY-STIMULATING FACTORS
Authors: ROSENFELD C PINEIRO L AGURA E NEMUNAITIS J COLLINS R
Citation: C. Rosenfeld et al., ALLOGENEIC BLOOD-CELL TRANSPLANTATION WITHOUT POSTTRANSPLANT COLONY-STIMULATING FACTORS, Blood, 86(10), 1995, pp. 365-365
THIOTEPA CARBOPLATIN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)/
Authors: CHRISTIANSEN NP PINEIRO L COLLINS R FAY J HERZIG G
Citation: Np. Christiansen et al., THIOTEPA CARBOPLATIN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)/, Blood, 86(10), 1995, pp. 3753-3753
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP
Authors: BROWN RA WOLFF SN FAY JW PINEIRO L COLLINS RH LYNCH JP STEVENS D GREER J HERZIG RH HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP, Blood, 85(5), 1995, pp. 1391-1395
HIGH-DOSE CYTOSINE-ARABINOSIDE (HDAC) DAUNORUBICIN (DNR) INDUCTION FOLLOWED BY HIGH-DOSE ETOPOSIDE (VP) CYCLOPHOSPHAMIDE (CY) CONSOLIDATIONFOR PATIENTS (PTS) WITH AML
Authors: BROWN RA WOLFF S FAY J PINEIRO L GREER J LYNCH J COLLINS R STEVENS D HERZIG R HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE CYTOSINE-ARABINOSIDE (HDAC) DAUNORUBICIN (DNR) INDUCTION FOLLOWED BY HIGH-DOSE ETOPOSIDE (VP) CYCLOPHOSPHAMIDE (CY) CONSOLIDATIONFOR PATIENTS (PTS) WITH AML, Blood, 84(10), 1994, pp. 10000146-10000146
ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS
Authors: TONG AW HUANG YW GHETIE V NEMUNAITIS J PINEIRO L VITETTA E STONE MJ
Citation: Aw. Tong et al., ENHANCEMENT OF ANTI-CD54 IMMUNOTOXIN CYTOTOXICITY TO HUMAN MULTIPLE-MYELOMA CELLS BY CYCLOSPORINE DRUGS, Blood, 84(10), 1994, pp. 10000170-10000170
PROSPECTIVE MULTICENTER TRIAL OF DONOR BUFFY COAT INFUSION FOR RELAPSED HEMATOLOGIC MALIGNANCY POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: COLLINS R WOLFF S LIST A CHRISTIANSEN N PINEIRO L GREER J GOODMAN S DALTON W GONZALEZ G HERZIG G PHILLIPS G FAY J
Citation: R. Collins et al., PROSPECTIVE MULTICENTER TRIAL OF DONOR BUFFY COAT INFUSION FOR RELAPSED HEMATOLOGIC MALIGNANCY POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000333-10000333
FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER UNRELATED MARROW DONOR (UMD) TRANSPLANTATION
Authors: FAY JW PINEIRO L COLLINS RH STEIN B ARO RM FITZSIMMONS WE
Citation: Jw. Fay et al., FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER UNRELATED MARROW DONOR (UMD) TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000708-10000708
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/
Authors: BROWN RA WOLFF S FAY J PINEIRO L GREEN J LYNCH J COLLINS R STEVENS D HERZIG R HERZIG GP
Citation: Ra. Brown et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) FOR PATIENTS WITH RESISTANT ACUTE MYELOID-LEUKEMIA (AML) - A PHASE-I-II TRIAL BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP/, Blood, 82(10), 1993, pp. 10000166-10000166
HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA - RESULTS FROM THE NORTH-AMERICAN-TRANSPLANT-GROUP/
Authors: PINEIRO L FAY J COLLINS R BROWN R HERZIG R WOLFF S PHILLIPS G HERZIG G
Citation: L. Pineiro et al., HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION (VP CY/TBI) AND ALLOGENEIC BONE-MARROW TRANSPLANT FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA - RESULTS FROM THE NORTH-AMERICAN-TRANSPLANT-GROUP/, Blood, 82(10), 1993, pp. 10000169-10000169
IMMUNOMODULATION RESULTING IN COMPLETE REMISSION IN PATIENTS (PTS) WITH RESIDUAL OR RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: COLLINS R PINEIRO L LANIER A FAY J
Citation: R. Collins et al., IMMUNOMODULATION RESULTING IN COMPLETE REMISSION IN PATIENTS (PTS) WITH RESIDUAL OR RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000417-10000417
PILOT TRIAL OF ALLOGENEIC TRANSPLANT COMBINING PERIPHERAL-BLOOD AND BONE-MARROW IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCY
Authors: NEMUNAITIS J ROSENFELD C COLLINS R PINEIRO L OHR S PALLANSCH P SHADDUCK R STONE M FAY J
Citation: J. Nemunaitis et al., PILOT TRIAL OF ALLOGENEIC TRANSPLANT COMBINING PERIPHERAL-BLOOD AND BONE-MARROW IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCY, Blood, 82(10), 1993, pp. 10000417-10000417
FLUCONAZOLE (FLUC) VERSUS LOW-DOSE AMPHOTERICIN-B (AMPHO) FOR THE PREVENTION OF FUNGAL-INFECTIONS IN PATIENTS (PTS) UNDERGOING MARROW TRANSPLANTATION (BMT) - A STUDY OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANT GROUP (NAMTG)
Authors: WOLFF S FAY J STEVENS D HERZIG R BOLWELL B LYNCH J FREYTES C LEMAISTRE F COLLINS R PINEIRO L GREER J STEIN R GOODMAN S ROGERS K DUMMER S
Citation: S. Wolff et al., FLUCONAZOLE (FLUC) VERSUS LOW-DOSE AMPHOTERICIN-B (AMPHO) FOR THE PREVENTION OF FUNGAL-INFECTIONS IN PATIENTS (PTS) UNDERGOING MARROW TRANSPLANTATION (BMT) - A STUDY OF THE NORTH-AMERICAN BONE-MARROW TRANSPLANT GROUP (NAMTG), Blood, 82(10), 1993, pp. 10000425-10000425
CONCOMITANT ADMINISTRATION OF INTERLEUKIN-6 (RHIL-6) AND LEUCOMAX(R) (RHGM-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION-A PHASE-I TRAIL
Authors: FAY JW COLLINS R PINEIRO L DUTCHER J GUCALP R GRINBLATT D LAZARUS HM WILLIAMS S COOPER BW MANFREDA S ISAACS R
Citation: Jw. Fay et al., CONCOMITANT ADMINISTRATION OF INTERLEUKIN-6 (RHIL-6) AND LEUCOMAX(R) (RHGM-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION-A PHASE-I TRAIL, Blood, 82(10), 1993, pp. 10000431-10000431
Risultati: 1-22 |